Online Only Articles

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia

Research Center LURM, University of Verona, Italy
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Qognit Inc., Foster City, CA, USA
Hematology, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland
Department of Medicine, Section of Hematology, University of Verona, Italy
Pierian Biosciences, Franklin, TN, USA
Research Center LURM, University of Verona, Italy
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Department of Cell Therapy and Hematology, San Bortolo Hospital, Vicenza, Italy
Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy
Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy
Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University of Verona, Italy
Department of Medicine, Hematology and Clinical Immunology Branch, University of Padua, Italy
Department of Medicine, Section of Hematology, University of Verona, Italy
Department of Translational Medicine, Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Department of Medicine, Section of Hematology, University of Verona, Italy
NanoString, Inc, Seattle, WA, USA
Research Center LURM, University of Verona, Italy;Department of Medicine, Section of Hematology, University of Verona, Italy
Vol. 102 No. 4 (2017): April, 2017 https://doi.org/10.3324/haematol.2016.154450